Cargando…
Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian Cancer
SIMPLE SUMMARY: Epithelial ovarian cancer (EOC) is the most lethal gynaecological cancer. Over 80% of cases have already spread at diagnosis, and these patients face a five-year survival rate of 35%. EOC cells often spread to the greater omentum, an abdominal fat pad. Here, EOC cells take-up cholest...
Autores principales: | Gao, Jixuan, Jung, MoonSun, Williams, Rebekka T., Hui, Danica, Russell, Amanda J., Naim, Andrea J., Kamili, Alvin, Clifton, Molly, Bongers, Angelika, Mayoh, Chelsea, Ho, Gwo, Scott, Clare L., Jessup, Wendy, Haber, Michelle, Norris, Murray D., Henderson, Michelle J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029800/ https://www.ncbi.nlm.nih.gov/pubmed/35454786 http://dx.doi.org/10.3390/cancers14081878 |
Ejemplares similares
-
CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements
por: Somers, Klaartje, et al.
Publicado: (2016) -
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma
por: Subhash, Vinod Vijay, et al.
Publicado: (2021) -
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction
por: Somers, Klaartje, et al.
Publicado: (2019) -
HIV hijacks cholesterol transporter ABCA1 to get access to cellular cholesterol
por: Bukrinsky, Michael, et al.
Publicado: (2009) -
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
por: Kamili, Alvin, et al.
Publicado: (2020)